Physiology and molecular genetics of multidrug resistance in Entamoeba histolytica

Drug Resistance Updates

Volumn 2, Issue 3, 1999, Pages 188-197

  Orozco, Esther ^a   Gómez, Consuelo ^a   Pérez, D Guillermo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; COLCHICINE; DIIODOHYDROXYQUIN; DILOXANIDE; EMETINE; GLYCOPROTEIN P; MESSENGER RNA; METRONIDAZOLE; MULTIDRUG RESISTANCE PROTEIN; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR AP 1;

CROSS RESISTANCE; CYTOPLASM; ENTAMOEBA HISTOLYTICA; EVOLUTION; GENE EXPRESSION; GENE INDUCTION; GENETIC CONSERVATION; HUMAN; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TROPHOZOITE;

EID: 0033150369     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.1999.0087     Document Type: Article

References (83)

1. Gottesman M. M., Hrycyna C. A. Genetic analysis of the multidrug transporter. Annu Rev Genet. 29:1995;607-649.
2. Dano K. Active outward transport of daunomycin in resistant Erlich ascites tumor cells. Biochem Biophys Acta. 323:1973;466-483.
3. Juliano R. L., Ling V. A. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 455:1976;152-162.
4. Koshiyama M., Yoshida M., Fujii H. Expression of multidrug resistance-associated protein in endometrial carcinomas: correlation with clinicopathology and prognosis. Ann Diagn Pathol. 2:1999;81-87.
5. Muller M., Meijer C., Zaman G. J. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA. 91:1994;13033-13037.
6. Leier I., Jedlitschky G., Buchholz U., Cole S. P., Deeley R. G., Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem. 269:1994;27807-27810.
7. Foote S. J., Thompson J. K., Cowman A. F., Kemp D. J. Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of Plasmodium falciparum. Cell. 57:1989;921-930.
8. Foote S. J., Kyle D. E., Martin R. K. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature. 345:1990;255-258.
9. Cowman A. F., Karz A., Galatis D., Culvenor J. G. A P-glycoprotein homologue of Plasmodium falciparum is localized in the digestive vacuole. J Cell Biol. 113:1991;1033-1042.
10. Cowman A. F., Galatis D., Thompson J. K. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA. 91:1994;1143-1147.
11. Ellenberger T. E., Beverly S. M. Multiple drug resistance and conservative amplification of the H region in Leishmania major. J Biol Chem. 264:1989;15094-15103.
12. Ouellette M., Fase-Fowler F., Borst P. The amplified H circle of methotrexate-resistant Leishmania tarentolae contains a novel P-glycoprotein gene. EMBO J. 9:1990;1027-1033.
13. Ouellette M., Papadopoulou B. Mechanisms of drug resistance in Leishmania. Parasitol Today. 9:1993;150-153.
14. Gamarro F., Amador M. V., Chiquero M. J., Legere D., Ouellette M., Castanys S. Multidrug resistance phenotype and P-glycoprotein overexpression in a methotrexate-resistant Leishmania infantum. Biochem Pharmacol. 47:1994;1939-1947.
15. Katakura K., Iwanami M., Ohtomo H. Structural and functional analysis of the LaMDR1 multidrug resistance gene in Leishmania amazonensis. Biochem Biophys Res Commun. 255:1999;289-294.
16. Dallagiovanna B., Castanys S., Gamarro F. Trypanosoma cruzi: sequence of the ATP-binding site of a P-glycoprotein. Exp Parasitol. 79:1994;63-67.
17. Johnson P. J., Schuck B. L., Delgadillo M. G. Analysis of a single-domain P-glycoprotein-like gene in the early-diverging protist Trichomonas vaginalis. Mol Biochem Parasitol. 66:1994;127-137.
18. Upcroft J. A., Upcroft P. Drug resistance and Giardia. Parasitol Today. 9:1993;187-190.
19. Ayala P., Samuelson J., Wirth D., Orozco E. Entamoeba histolytica: physiology of multidrug resistance. Exp Parasitol. 71:1990;169-175.
20. Orozco E., Pérez D. G., Gómez M. C., Ayala P. Multidrug resistance in Entamoeba histolytica. Parasitol Today. 11:1995;473-475.
21. Zalis M. G., Wilson C. M., Zhang Y., Wirth D. F. Characterization of the pfmdr2 gene for Plasmodium falciparum. Mol Biochem Parasitol. 62:1993;83-92.
22. Ouellette M., Borst P. Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania. Res Microbiol. 142:1991;737-746.
23. Descoteaux S., Ayala P., Orozco E., Samuelson J. Primary sequences of two P-glycoprotein genes of Entamoeba histolytica. Mol Biochem Parasitol. 54:1992;201-212.
24. Descoteaux S., Ayala P., Samuelson J., Orozco E. Increase in mRNA of multiple EhPgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. Gene. 164:1995;179-184.
25. Volkman S. K., Cowman A. F., Wirth D. F. Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdr1 gene of Plasmodium falciparum. Proc Natl Acad Sci USA. 93:1996;3479-3471.
26. Jones P. M., George A. M. A new structural model for P-glycoprotein. J Membrane Biol. 166:1998;133-147.
27. Chen C. J., Chin J. E., Ueda K. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 47:1986;381-389.
28. Gros P., Croop J., Housman D. E. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins. Cell. 47:1986;371-380.
29. Townson S. H., Laqua H., Upcroft P., Boreham P. F. L., Upcroft J. A. Induction of metronidazole and furazolidone resistance in Giardia. Trans R Soc Trop Med Hyg. 86:1992;521-522.
30. Foote S. J., Cowman A. F. The mode of action and the mechanism of resistance to antimalarial drugs. Acta Trop. 56:1994;157-171.
31. Dey S., Papadopoulou B., Roy G. High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system. Mol Biochem Parasitol. 67:1994;49-57.
32. Singh A. K., Liu H. Y., Lee S. T. Atomic absorption spectrophotometric measurement of intracellular arsenite in arsenite-resistantLeishmania. Mol Biochem Parasitol. 66:1994;161-164.
33. Papadopoulou B., Roy G., Dey S., Rosen B. P., Ouellette M. Contribution of the Leishmania P-glycoprotein related gene ltpgpA to oxyanion resistance. J Biol Chem. 269:1994;11980-11986.
34. Orozco E., Hernández F., Rodríguez M. A. Isolation and characterization of Entamoeba histolytica mutants resistant to emetine. Mol Biochem Parasitol. 15:1985;49-59.
35. Samuelson J. C., Burke A., Courval J. M. Susceptibility of an emetine-resistant mutant of Entamoeba histolytica to multiple drugs and to channel blockers. Antimicrobial Agents and Chemotherapy. 36:1992;2392-2397.
36. Bacchi C. J. Resistance to clinical drugs in African trypanosomes. Parasitol Today. 9:1993;190-193.
37. Fairlamb A. H., Carter N. S., Cunningham M., Smith K. Characterization of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Mol Biochem Parasitol. 53:1992;213-222.
38. Martin S. K., Oduola A. M. J., Milhous W. K. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science. 235:1987;899-901.
39. Beverly S. M. Gene amplification in Leishmania. Annu Rev Microbiol. 45:1991;417-444.
40. Ouellette M., Légaré D., Papadopoulou B. Microbial multidrug resistance ABC transporters. Trends Microbiol. 2:1994;407-411.
41. Van Es H. H. G., Karez S., Chu F. Expression of the plasmodial pfmdr1 gene in mammalian cells is associated with increased susceptibility to chloroquine. Mol Cell Biol. 14:1994;2419-2428.
42. Callahan H. L., Beverly S. M. Heavy metal resistance: a new role for P-glycoproteins in Leishmania. J Biol Chem. 266:1991;18427-18430.
43. Ghosh S. K., Lohia A., Kumar A., Samuelson J. Overexpression of P-glycoprotein gene 1 by transfected Entamoeba histolytica confers emetine-resistance. Mol Biochem Parasitol. 82:1996;257-260.
44. World Health Organization. 1997; 72: 97-100.
45. Lindmark D. G., Muller M. Antitrichomonad action mutagenicity, and reduction of metronidazole and other nitroimidazoles. Antimicrob Agents Chemother. 10:1976;476-482.
46. LaRusso N. F., Tomas M., Muller M., Lipman R. Interaction of metronidazole with nucleic acids in vitro. Mol Pharmacol. 13:1977;872-882.
47. Knigth R. C., Skolimowski I. M., Edwars D. I. The interaction of reduced metronidazole with DNA. Biochem Pharmacol. 27:1978;2089-2093.
48. Hrdy I., Muller M. Primary structure and eubacterial relationships of the piruvate: ferredoxin oxidoreductase of the amitochondriate eukariote Trichomonas vaginalis. J Mol Evol. 41:1995;388-396.
49. Rodríguez M. A., Hidalgo M. E., Sánchez T., Orozco E. Cloning and characterization of the Entamoeba histolytica pyruvate:ferredoxin oxidoreductase gene. Mol Biochem Parasitol. 78:1996;273-27750.
50. Yarlett N., Yarlet N. C., Lloyd D. Ferredoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains ofTrichomonas vaginalis. Biochem Pharmacol. 35:1986;1703-1708.
51. Grollman A. P. Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics. Proc Natl Acad Sci USA. 56:1966;1867-1874.
52. Huang M. T., Grollman A. P. Novel inhibitors of protein synthesis in animal cells. Fed Proc. 29:1970;609 Abs.
53. Cedeño J. R., Krogstad D. J. Susceptibility testing of Entamoeba histolytica. J Infect Dis. 148:1983;1090-1096.
54. Burchard G. D., Mirelman D. Entamoeba histolytica: virulence potential and sensitivity to metronidazole and emetine of four isolates possessing nonpathogenic zymodemes. Exp Parasitol. 66:1988;231-242.
55. Samarawickrema N. A., Brown D. M., Upcroft J. A., Thammapalerd N., Upcroft P. Involvement of surperoxide dismutase and piruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance inEntamoeba histolytica. J Antimicrob Chemoter. 40:1997;833-840.
56. Weber D. M. Amebic abscess of liver following metronidazole therapy. JAMA. 216:1971;1339-1340.
57. Pittman F. E., Pittman J. C. Amebic liver abscess following metronidazole therapy for amoebic colitis. Am J Trop Med Hyg. 23:1974;146-150.
58. de la Torre M., de la Hoz-Couturier R., Landa L., Sepúlveda B. Cultivos axénicos de Entamoeba histolytica. Arch Med Res. 2:1971;165-172.
59. Tannich E., Horstmann R. D. Codon use in pathogenic Entamoeba histolytica. J Mol Evol. 34:1992;272-273.
60. Samuelson J., Ayala P., Orozco E., Wirth D. Emetine resistant mutants of Entamoeba histolytica overexpress mRNAs for multidrug resistance. Mol Biochem Parasitol. 38:1990;281-290.
61. Gómez C., Pérez D. G., López-Bayghen E., Orozco E. Transcriptional analysis of the EhPgp1 promoter of Entamoeba histolytica multidrug-resistant mutant. J Biol Chem. 273:1998;7277-7284.
62. Camarillo C., Gómez C., Pérez D., Flores E., Orozco E. Putative amplification of the EhPgp genes in Entamoeba histolytica emetine-resistant mutant. Arch Med Res. 28:1997;S66-S68.
63. Higgins C. The multidrug resistance P-glycoprotein. Curr Op Cell Biol. 5:1993;684-687.
64. Pérez D. G., Gómez C., López-Bayghen E., Tannich E., Orozco E. Transcriptional analysis of the EhPgp5 promoter of Entamoeba histolytica multidrug-resistant mutant. J Biol Chem. 273:1998;7285-7292.
65. Shen D. W., Fojo A., Chin J. E. Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification. Science. 232:1986;643-645.
66. Gottesman M. M., Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 62:1993;385-427.
67. Devault A., Gros P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities. Mol Cell Biol. 10:1990;1652-1663.
68. Nickel R., Tannich E. Transfection and transient expression of chloramphenicol acetyltransferase gene in the protozoan parasite Entamoeba histolytica. Proc Natl Acad Sci USA. 91:1994;7095-7098.
69. Purdy J. E., Mann B. J., Pho L. T., Petri W. A. Jr. Transient transfection of the enteric parasite Entamoeba histolytica and expression of the firely luciferase. Proc Natl Acad Sci USA. 91:1994;7099-7103.
70. Fojo A. T., Ueda K., Slamon D. J., Poplack D. G., Gottesman M. M., Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA. 84:1987;265-269.
71. Madden M. J., Morrow C. S., Nakagawa M., Goldsmith M. E., Fairchild C. R., Cowan K. H. Identification of the 5′ and 3′ sequences involved in the regulation of transcription of the humanMDR1 gene in vivo. J Biol Chem. 268:1993;8290-8297.
72. Bruchhaus I., Lieppe M., Lioutas C., Tannich E. Unusual gene organization in the protozoan parasite Entamoeba histolytica. DNA Cell Biol. 12:1993;925-933.
73. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., Smale S. T. DNA sequence requirements for transcriptional Initiator activity in mammalian cells. Mol Cell Biol. 14:1994;116-127.
74. Smit J. J., Mol C. A., van Deemter L., Wagenaar E., Schinkel A. H., Borst P. Characterization of the promoter region of the human MDR3 P-glycoprotein gene. Biochim Biophys Acta. 1261:1995;44-56.
75. Purdy J. E., Pho L. T., Mann B. J., Petri W. A. Jr. Upstream regulatory elements controlling expression of the Entamoeba histolytica lectin. Mol Biochem Parasitol. 78:1996;91-103.
76. Cereghini S., Raymondjean M., García C. A., Herbomel P., Yaniv M. Factors involved in control of tissue-specific expression of albumin gene. Cell. 50:1987;627-638.
77. Grange T., Roux J., Rigaud G., Pictet R. Cell-type specific activity of two glucocorticoid responsive units of rat tyrosine aminotransferase gene is associated with multiple binding sites for C/EBP and novel liver-specific nuclear factor. Nucleic Acids Res. 19:1991;131-135.
78. Yu L., Wu Q., Yang C. P., Horwitz S. B. Coordination of transcription factors, NF-Y and C/EBP beta, in the regulation of the mdr1b promoter. Cell Growth Differ. 6:1995;1505-1512.
79. Yu L., Cohen D., Piekarz R., Horwitz S. Three distinct nuclear protein binding sites in the promoter of the murine multidrug resistance mdr1b gene. J Biol Chem. 268:1993;7520-7526.
80. Raymond M., Rose E., Housman D., Gross P. Physical mapping, amplification and overexpression of the mouse mdr gene family in multidrug-resistant cells. Mol Cell Biol. 10:1990;1642-1651.
81. Lavelle D., Duckswoth E., Eves E. A homeodomain protein binds to γ-globin gene regulatory sequences. Proc Natl Acad Sci USA. 88:1991;7318-7322.
82. Batist G., Tulpule A., Sinha B. K., Katki A. G., Myers C. E., Cowans K. Overexpression of a novel anionic glutatione transferase in multidrug-resistant human breast cancer cell. J Biol Chem. 261:1986;15544-15549.
83. Kramer R. A., Zakher J., Kim G. Role of the glutathion rodex cycle in acquired and novo multidrug resistance. Science. 241:1988;694-697.